SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%
 

← Persons Index

Patrick Soon-Shiong
Rank #404 · Healthcare

Patrick Soon-Shiong

Pharmaceuticals · United States

Net worth$8.9B
Today−$353M
7 days−$41K
30 days−$1.5B

Net worth, last 30 days

Low $8.9BHigh $10.8B

Biography

Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer.

He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion.

He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016.

He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers.

He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018.

In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.

Did you know

Soon-Shiong graduated from high school at age 16 and became a doctor at 23.

Soon-Shiong was born in South Africa to Chinese immigrants.

Holdings

CompanyTickerSharesValue
AllscriptsMDRX-US3,071,000$15M
Benitec BiopharmaBNTC-US293,000$2.4M
Bristol-Myers Squibb Co.BMY-US8,155,296$476M
Celgene CorporationCELG-US0$0
Contingent Value Rights for Celgene CorporationCELGZ-US0$0
Directa PlusDCTA-GB0$0
ImmunityBio IncIBRX-US648,994,010$4.3B
ImmunityBio IncIBRX-US900,000$5.9M
JAKKS Pacific Inc.JAKK-US0$0
Liminal BioSciencesLMNL-CA0$0
NantHealthNHIQ-US0$0
RadNet Inc.RDNT-US561,000$39M
Sorrento TherapeuticsSRNE-US0$0
Tribune PublishingTPCO-US0$0
Private assets & other$4.5B

Public holdings ≈ $4.8B. Holdings may include options and overlap between rows.